Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 14.74 is 38% below its 5-year average of 23.75, near the low end of its 5-year range (12.84–62.88).
As of the fiscal period ended Tuesday, June 30, 2026. 6.35% below its 12-month average of 15.74.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 14.74.
CURRENT RATIO
14.74
CURRENT RATIO AVG TTM
15.74
CURRENT RATIO AVG 3Y
19.21
CURRENT RATIO AVG 5Y
23.75
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-6.35%
CURRENT VS 3Y AVG
-23.24%
CURRENT VS 5Y AVG
-37.94%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+293.12%
vs the sector median at left
Market Cap
$120.58M
Current Ratio
10.21
TTM Avg
11.59
3Y Avg
10.00
5Y Avg
8.96
Market Cap
$118.83M
Current Ratio
13.55
TTM Avg
17.30
3Y Avg
10.78
5Y Avg
9.73
Market Cap
$118.59M
Current Ratio
4.52
TTM Avg
5.53
3Y Avg
5.99
5Y Avg
10.25
Market Cap
$122.66M
Current Ratio
6.61
TTM Avg
6.96
3Y Avg
5.91
5Y Avg
6.89
Market Cap
$117.76M
Current Ratio
9.23
TTM Avg
4.04
3Y Avg
4.74
5Y Avg
7.63
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Seer, Inc. (SEER) | $120.41M | 14.74 | 15.74 | 19.21 | 23.75 |
| enGene Holdings Inc. (ENGN)vs › | $120.58M | 10.21 | 11.59 | 10.00 | 8.96 |
| Cibus, Inc. (CBUS)vs › | $119.84M | 1.62 | 0.78 | 1.43 | 2.42 |
| LENZ Therapeutics, Inc. (LENZ)vs › | $118.83M | 13.55 | 17.30 | 10.78 | 9.73 |
| Tenaya Therapeutics, Inc. (TNYA)vs › | $118.59M | 4.52 | 5.53 | 5.99 | 10.25 |
| BGM Group Ltd. (BGM)vs › | $122.43M | 1.25 | 2.31 | 3.27 | 2.89 |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $122.66M | 6.61 | 6.96 | 5.91 | 6.89 |
| Spruce Biosciences, Inc. (SPRB)vs › | $117.76M | 9.23 | 4.04 | 4.74 | 7.63 |
| MaxCyte, Inc. (MXCT)vs › | $116.76M | 12.26 | 9.59 | 11.55 | 11.23 |
| TuHURA Biosciences, Inc. (HURA)vs › | $124.18M | 0.18 | 2.23 | 2.69 | 2.63 |
Current Ratio
14.74
Quick Ratio
14.06
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 14.74 |
| 2026-03-31 | 17.73 |
| 2025-12-31 | 12.84 |
| 2025-09-30 | 14.25 |
| 2025-06-30 | 19.15 |
| 2025-03-31 | 19.34 |
| 2024-12-31 | 16.53 |
| 2024-09-30 | 18.36 |
| 2024-06-30 | 17.59 |
| 2024-03-31 | 25.27 |
| 2023-12-31 | 25.00 |
| 2023-09-30 | 27.65 |
| 2023-06-30 | 21.22 |
| 2023-03-31 | 31.26 |
| 2022-12-31 | 34.57 |
| 2022-09-30 | 33.08 |
| 2022-06-30 | 31.07 |
| 2022-03-31 | 41.02 |
| 2021-12-31 | 30.67 |
| 2021-09-30 | 53.83 |
| 2021-06-30 | 62.88 |
| 2021-03-31 | 72.50 |
| 2020-12-31 | 53.51 |
| 2020-09-30 | 21.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 22.75 |
